Infectious Disease

Experimental human colonisation with non-toxigenic Clostridioides difficile: a placebo-controlled randomised clinical trial. | ClinicLens

Clostridioides difficile infections remain a major global healthcare burden, underscoring the need for novel therapies. Human colonisation models provide mechanistic insight into C. difficile colonisation and facilitate identification of novel intervention targets. We conducted a

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.